Carlos Hernandez
Psychiatry · Houston, TXNPI 1902812548
Payments from drug & device makers
Across 184 payments — averaging $37.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$972
- Takeda Pharmaceuticals U.S.A., Inc.$483
- Otsuka America Pharmaceutical, Inc.$464
- Axsome Therapeutics, Inc.$453
- Sunovion Pharmaceuticals Inc.$433
- plus $3K from 19 others
What the payments were for
- Speaking & faculty fees$5007%
- Food & beverage$6,34893%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,074 |
| Supernus Pharmaceuticals, Inc. | 9 | $972 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $483 |
| Otsuka America Pharmaceutical, Inc. | 18 | $464 |
| Axsome Therapeutics, Inc. | 8 | $453 |
| Sunovion Pharmaceuticals Inc. | 12 | $433 |
| Lundbeck LLC | 18 | $406 |
| Johnson & Johnson | 6 | $330 |
| Ironshore Pharmaceuticals Inc. | 6 | $317 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $260 |
| Corium, LLC | 8 | $249 |
| Teva Pharmaceuticals USA, Inc. | 2 | $229 |
| Biogen | 2 | $180 |
| Vanda Pharmaceuticals Inc. | 3 | $165 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $102 |
| Shire North American Group Inc | 4 | $97 |
| Novo Nordisk | 1 | $96 |
| Pharming Healthcare, Inc. | 1 | $94 |
| Medtronic | 1 | $90 |
| Neos Therapeutics, LP | 3 | $57 |
| Alkermes, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,850 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $905 |
| Bupropion XlBupropion Hcl | 16 | $774 |
| Escitalopram Oxalate | 29 | $589 |
| Duloxetine Hcl | 19 | $509 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $508 |
| Aripiprazole | 17 | $489 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $347 |
| Sertraline Hcl | 25 | $285 |
| Trazodone Hcl | 42 | $258 |
| Buspirone Hcl | 14 | $214 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $161 |
| Lithium Carbonate | 12 | $98 |
| Quetiapine Fumarate | 11 | $65 |
| Alprazolam | 20 | $49 |
| Risperidone | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$3M
- Lawrence GinsbergHouston$2.4M
- Asim ShahHouston$2.2M
- Aqeel HashmiHouston$1.3M
- Robert EarleHouston$1.1M
- Frank ChenHouston$941K
- Joao de QuevedoHouston$890K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.